# Botulinum Toxin-A for Hidradenitis Suppurativa

> **NCT06237465** · PHASE4 · WITHDRAWN · sponsor: **Yale University**

## Conditions studied

- Hidradenitis Suppurativa
- Hidradenitis Suppurativa \(HS\)
- Hidradenitis Suppurativa, Acne Inversa

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Botulinum toxin type A

## Key facts

- **NCT ID:** NCT06237465
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01
- **Primary completion:** 2025-06
- **Final completion:** 2026-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never officially began (or enrolled)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237465, "Botulinum Toxin-A for Hidradenitis Suppurativa". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06237465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*